MK
MERCK Kommanditgesellschaft auf Aktien
MKGAF · OTC
$155.02 -2.58% (-$4.10)
1M -4.38%
Market Cap 59.6B €
P/E Ratio 25.10x
Div. Yield 1.62%
ROE 7.75%
Bulios Fair Price
$82.87
46.5% downside
Current Price
$155.02
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MKGAF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
65 /100
Fair P/E 25.10x
EV/EBITDA 10.10x
P/S 2.82x
Growth
13 /100
Declining EPS growth 7.78%
Rev. growth 1.74%
FCF growth 1.46%
Profitability
83 /100
Strong Gross margin 58.70%
Net margin 11.22%
Op. margin 19.70%
Quality
38 /100
Average ROIC 7.18%
ROE 7.75%
ROA 4.51%
Debt
82 /100
Low Debt/Equity 0.41x
Current ratio 1.69x
Int. coverage 8.64x
Stability
100 /100
Stable Beta 0.83x
Rev. volatility 3.40%
EPS volatility 6.80%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MKGAF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Kai Beckmann
Employees
62,461
Headquarters
Darmstadt
Upcoming events
12 NOV
Earnings
Upcoming earnings report